stevioside: Kaurene glucoside from leaves of Stevia rebaudiana; 300 times as sweet as sugar [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]
stevioside : A diterpene glycoside that is rubusoside in which the hydroxy group at position 2 of the allylic beta-D-glucoside has been converted to the corresponding beta-D-glucoside. It is a natural herbal sweetener that is 250-300 times sweeter than sucrose (though with a bitter aftertaste), extracted from the Stevia rebaudiana plant native to South America. [Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]
diterpene glycoside : A terpene glycoside in which the terpene moiety is a diterpenoid. [Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]
Flora | Rank | Flora Definition | Family | Family Definition |
---|---|---|---|---|
Stevia | genus | A plant genus of the family ASTERACEAE. Members contain stevioside and other sweet diterpene glycosides. The leaf is used for sweetening (SWEETENING AGENTS).[MeSH] | Asteraceae | A large plant family of the order Asterales, subclass Asteridae, class Magnoliopsida. The family is also known as Compositae. Flower petals are joined near the base and stamens alternate with the corolla lobes. The common name of daisy refers to several genera of this family including Aster; CHRYSANTHEMUM; RUDBECKIA; TANACETUM.[MeSH] |
Stevia rebaudiana | species | [no description available] | Asteraceae | A large plant family of the order Asterales, subclass Asteridae, class Magnoliopsida. The family is also known as Compositae. Flower petals are joined near the base and stamens alternate with the corolla lobes. The common name of daisy refers to several genera of this family including Aster; CHRYSANTHEMUM; RUDBECKIA; TANACETUM.[MeSH] |
ID Source | ID |
---|---|
PubMed CID | 442089 |
CHEMBL ID | 444122 |
CHEBI ID | 9271 |
SCHEMBL ID | 33428 |
MeSH ID | M0058754 |
Synonym |
---|
1-o-{(5beta,8alpha,9beta,10alpha,13alpha)-13-[(2-o-beta-d-glucopyranosyl-beta-d-glucopyranosyl)oxy]-18-oxokaur-16-en-18-yl}-beta-d-glucopyranose |
(4alpha)-beta-d-glucopyranosyl 13-((2-o-beta-d-glucopyranosyl-beta-d-glucopyranosyl)oxy)kaur-16-en-18-oate |
steviosin |
brn 0077427 |
ccris 6116 |
kaur-16-en-18-oic acid, 13-((2-o-beta-d-glucopyranosyl-alpha-d-glucopyranosyl)oxy)-, beta-d-glucopyranosyl ester |
einecs 260-975-5 |
13-[(2-o-.beta.-d-glucopyranosyl-.alpha.-d-glucopyranosyl)oxy]kaur-16-en-18-oic acid .beta.-d-glucopyranosyl ester |
diterpene glycoside |
[(2s,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)tetrahydropyran-2-yl] [(2s,3r,4s,5s,6r)-4,5-dihydroxy-6-(hydroxymethyl)-3-[(2s,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)tetrahydropyran-2-yl]oxy-tetrahydropyran-2-yl]oxy-dimethyl-methylene-[?]carbo |
C09189 , |
57817-89-7 |
stevioside |
CHEMBL444122 , |
chebi:9271 , |
0yon5mxj9p , |
unii-0yon5mxj9p |
4-17-00-03618 (beilstein handbook reference) |
e-960 |
(-)-stevioside |
fema no. 4763 |
kaur-16-en-18-oic acid, 13-((2-o-.beta.-d-glucopyranosyl-.beta.-d-glucopyranosyl)oxy)-, .beta.-d-glucopyranosyl ester, (4.alpha.)- |
stevioside [mi] |
stevian 50 |
ins no.960 |
(4.alpha.)-13-((2-o-.beta.-d-glucopyranosyl-.beta.-d-glucopyranosyl)oxy)kaur-16-en-18-oic acid .beta.-d-glucopyranosyl ester |
.alpha.-g-sweet |
ins-960 |
stevibioside |
stevioside [usp-rs] |
stevioside [mart.] |
stevioside [inci] |
AKOS015895872 |
UEDUENGHJMELGK-HYDKPPNVSA-N |
SCHEMBL33428 |
1-o-{13alpha-[(2-o-beta-d-glucopyranosyl-beta-d-glucopyranosyl)oxy]-18-oxo-5beta,8alpha,9beta,10alpha-kaur-16-en-18-yl}-beta-d-glucopyranose |
13-[(2-o-beta-d-glucopyranosyl-beta-d-glucopyranosyl)oxy]kaur-16-en-18-oic acid beta-d-glucopyranosyl ester |
DTXSID7021281 , |
bdbm50480264 |
rebaudin |
stevin? |
eupatorin? |
DS-6711 |
Q415043 |
HY-N0669 |
CS-W019786 |
kaur-16-en-18-oic acid,13-[(2-o-b-d-glucopyranosyl-b-d-glucopyranosyl)oxy]-,b-d-glucopyranosyl ester, (4a)- |
gtpl12423 |
dtxcid301281 |
stevioside (usp-rs) |
13-((2-o-beta-d-glucopyranosyl-beta-d-glucopyranosyl)oxy)kaur-16-en-18-oic acid beta-d-glucopyranosyl ester |
kaur-16-en-18-oic acid, 13-((2-o-beta-d-glucopyranosyl-beta-d-glucopyranosyl)oxy)-, beta-d-glucopyranosyl ester, (4alpha)- |
alpha-g-sweet |
stevioside (mart.) |
13-((2-o-.beta.-d-glucopyranosyl-.alpha.-d-glucopyranosyl)oxy)kaur-16-en-18-oic acid .beta.-d-glucopyranosyl ester |
(4alpha)-13-((2-o-beta-d-glucopyranosyl-beta-d-glucopyranosyl)oxy)kaur-16-en-18-oic acid beta-d-glucopyranosyl ester |
1-o-(13alpha-((2-o-beta-d-glucopyranosyl-beta-d-glucopyranosyl)oxy)-18-oxo-5beta,8alpha,9beta,10alpha-kaur-16-en-18-yl)-beta-d-glucopyranose |
Stevioside (SVS) is a diterpenoid glycoside extracted from Stevia rebaudiana Bertoni. It has anti-inflammatory, immunomodulatory, anti-diabetic, and renal protective effects. Its effect on lipopolysaccharide (LPS)-induced epithelial-to-mesenchymal transition (EMT) of renal tubular epithelial cells remains unknown.
Stevioside has a complex diterpenoid glycoside molecule comprised of an aglycone, steviol with the ent-kaurane skeleton and three molecules of glucose. It has been shown to cause a decrease in the malondialdehyde formation rate, an increase in the activities of antioxidant enzymes and the accumulation of proline and carotenoids.
Excerpt | Reference | Relevance |
---|---|---|
"Stevioside may increase the insulin secretion, in part, by induction of genes involved in glycolysis." | ( Antihyperglycemic and blood pressure-reducing effects of stevioside in the diabetic Goto-Kakizaki rat. Agger, A; Colombo, M; Gregersen, S; Hermansen, K; Jeppesen, PB; Jepsen, M; Kruhøffer, M; Orntoft, T; Rolfsen, SE; Xiao, J, 2003) | 1.29 |
Stevioside treatment significantly ameliorates the adjuvant induced arthritic scoring, histological alterations, paw volume, elevation of biochemical (AST, ALT, ALP and glucose levels) and haematological (haemoglobin, differential and platelet count) parameters. It also restored the endogenous anti-oxidant (SOD, CAT, GSH and GST) activities.
Excerpt | Reference | Relevance |
---|---|---|
"Stevioside treatment significantly ameliorates the adjuvant induced arthritic scoring, histological alterations, paw volume, elevation of biochemical (AST, ALT, ALP and glucose levels) and haematological (haemoglobin, differential and platelet count) parameters and restored the endogenous anti-oxidant (SOD, CAT, GSH and GST) activities." | ( Anti-inflammatory effect of stevioside abates Freund's complete adjuvant (FCA)-induced adjuvant arthritis in rats. Alavala, S; Jerald, MK; Kilari, EK; Kuncha, M; Nalban, N; Sangaraju, R; Sistla, R, 2020) | 1.57 |
"Stevioside treatment significantly inhibited the levels of pro-inflammatory cytokines, TNF-α and IL-6, and the protein expressions of pro-inflammatory mediators, COX-2 (P < 0.01) and iNOS (P < 0.01) and restored the levels of endogenous anti-oxidants such as superoxide dismutase (P < 0.01), catalase (P < 0.001), glutathione s-transferase (P < 0.001) and reduced glutathione (P < 0.001) level in colon tissues." | ( Stevioside, a diterpenoid glycoside, shows anti-inflammatory property against Dextran Sulphate Sodium-induced ulcerative colitis in mice. Alavala, S; Jerald, MK; Kilari, EK; Nalban, N; Sahu, BD; Sangaraju, R; Sistla, R, 2019) | 2.68 |
"In stevioside-pretreated rats, the amount of verapamil needed to produce the decrease in heart rate was significantly lower compared to the control." | ( Effect of aqueous solution of stevioside on pharmacological properties of some cardioactive drugs. Budakov, Z; Mikov, I; Mikov, M; Milijasević, B; Rasković, A; Vasović, V; Vukmirović, S, 2014) | 1.2 |
"Stevioside treatment improved adipose tissue maturation, and increased glucose transport, insulin signaling and antioxidant defense in white visceral adipose tissues." | ( Stevioside inhibits atherosclerosis by improving insulin signaling and antioxidant defense in obese insulin-resistant mice. Benhabilès, N; Crombé, F; Geeraert, B; Geuns, JM; Holvoet, P; Hulsmans, M, 2010) | 2.52 |
"Stevioside treatment was associated with improved insulin signaling and antioxidant defense in both the adipose tissue and the vascular wall, leading to inhibition of atherosclerotic plaque development and inducing plaque stabilization." | ( Stevioside inhibits atherosclerosis by improving insulin signaling and antioxidant defense in obese insulin-resistant mice. Benhabilès, N; Crombé, F; Geeraert, B; Geuns, JM; Holvoet, P; Hulsmans, M, 2010) | 3.25 |
"Treatment with stevioside also significantly prevented the adjuvant induced elevation of pro-inflammatory cytokines (TNF-α, IL-6 and IL-1β), pro-inflammatory protein expressions (iNOS, COX-2, NF-κB (p65) and pIκB/IκB ratio), prevented the increase in myeloperoxidase activity and significantly restored the anti-inflammatory (IL-10) cytokine level in paw tissues." | ( Anti-inflammatory effect of stevioside abates Freund's complete adjuvant (FCA)-induced adjuvant arthritis in rats. Alavala, S; Jerald, MK; Kilari, EK; Kuncha, M; Nalban, N; Sangaraju, R; Sistla, R, 2020) | 1.19 |
"Pretreatment with stevioside caused no significant increase in blood glucose concentration after administering adrenaline, which was not the case with the animals pretreated with stevia and control." | ( Glucose concentration in the blood of intact and alloxan-treated mice after pretreatment with commercial preparations of Stevia rebaudiana (Bertoni). Gavrilovic, M; Jakovljevic, V; Raskovic, A; Sabo, J, ) | 0.45 |
Excerpt | Reference | Relevance |
---|---|---|
"0 g/kg BW/day were highly toxic to both dams and fetuses." | ( Developmental toxicity of steviol, a metabolite of stevioside, in the hamster. Glinsukon, T; Mungkornkarn, P; Suttajit, M; Temcharoen, P; Toskulkao, C; Wasuntarawat, C, 1998) | 0.55 |
"The review consist of modern data of physiologic and toxic effects on organism of sweetening stevioside with low energy value." | ( [Study of physiological and toxic effects of a sweetening agent stevioside (review of the literature)]. Smirnova, MG, 2001) | 0.77 |
Excerpt | Reference | Relevance |
---|---|---|
" Steviol glucuronide appeared in the plasma of all subjects after administration of rebaudioside A or stevioside, with median tmax values of 12." | ( Pharmacokinetics of rebaudioside A and stevioside after single oral doses in healthy men. Boileau, AC; Compton, JC; Jiang, X; Mandarino, DA; Prakash, I; Wheeler, A; Winkler, PC, 2008) | 0.83 |
Excerpt | Reference | Relevance |
---|---|---|
"Complexation of known drugs with carbohydrate-containing plant metabolites is a promising way to synthesize new drugs that does not only save pharmacological properties of initial agent but also acquire a number of advantageous features such as increased water solubility, bioavailability and decreased toxicity." | ( The complexes of drugs with carbohydrate-containing plant metabolites as pharmacologically promising agents. Bryzgalov, AO; Khvostov, MV; Tolstikova, TG, 2009) | 0.35 |
" About 40% of drugs are not soluble in water in practice and therefore are slowly absorbed, which results in insufficient and uneven bioavailability and GI toxicity." | ( Production of rubusoside from stevioside by using a thermostable lactase from Thermus thermophilus and solubility enhancement of liquiritin and teniposide. Jung, SJ; Kang, HK; Kim, D; Kim, M; Kim, YM; Moon, YH; Nguyen, TT, 2014) | 0.69 |
" However, low aqueous solubility and consequent poor bioavailability of curcuminoids are major limitations to their use." | ( Facile preparation of water soluble curcuminoids extracted from turmeric (Curcuma longa L.) powder by using steviol glucosides. Chung, B; Chung, D; Kang, C; Kim, D; Nguyen, TTH; Si, J, 2017) | 0.46 |
"Glycosylation is a key modification that contributes to determine bioactivity and bioavailability of plant natural products, including that of terpenoids and steviol glycosides (SVglys)." | ( Development of screening methods for functional characterization of UGTs from Stevia rebaudiana. Berger, M; Camborde, L; Daydé, J; Jacques, A; Petit, E; Vallejo, V, 2020) | 0.56 |
" The synthesized MDs with CMS biosurfactant coating exhibited significant water stability that resulted in a remarkable specific absorption rate of 209." | ( (Carboxymethyl-stevioside)-coated magnetic dots for enhanced magnetic hyperthermia and improved glioblastoma treatment. Gupta, R; Sharma, D, 2021) | 0.97 |
Excerpt | Relevance | Reference |
---|---|---|
" Adult male Wistar rats received stevioside orally at an accepted daily dosage of 10 mg kg⁻¹ for 7 days before cardiotoxin injection at the tibialis anterior (TA) muscle of the right hindlimb (the left hindlimb served as control), and stevioside administration was continued for 3 and 7 days." | ( Stevioside enhances satellite cell activation by inhibiting of NF-κB signaling pathway in regenerating muscle after cardiotoxin-induced injury. Bunprajun, T; Chatsudthipong, V; Muanprasat, C; Soodvilai, S; Yimlamai, T, 2012) | 2.1 |
" These results could help with the appropriate dosage selection for focused behavioral and physiological studies on stevia." | ( Stevia preferences in Wistar rats. Argüelles Luis, J; Núñez Martínez, P; Perillán Méndez, C, 2016) | 0.43 |
" They are recognized as generally recognized as safe by the US-FDA and approved by EU-European Food Safety Authority, with some recommendation on the daily dosage that should not interfere with glucose metabolism." | ( Tandem mass spectrometry: a convenient approach in the dosage of steviol glycosides in Stevia sweetened commercial food beverages. Di Donna, L; Mazzotti, F; Santoro, I; Sindona, G, 2017) | 0.46 |
" The production of steviol glycosides presented a biphasic dose-response suggestive of hormesis, with the highest values at 10 mg/L PSNPs (1." | ( Effects of polystyrene nanoplastics exposure on in vitro-grown Stevia rebaudiana plants. Clapa, D; Coman, C; Coman, V; Iancu, ȘD; Leopold, LF; Leopold, N; Scurtu, VF, 2023) | 0.91 |
Product Category | Products |
---|---|
Produits de la mer, Crustacés, Crevettes | 1 |
Comidas preparadas, Platos de pasta, Lasaña preparada, Lasaña de verduras | 1 |
Beauty & Personal Care | 5 |
Product | Brand | Category | Compounds Matched from Ingredients | Date Retrieved |
---|---|---|---|---|
Clean Age Toothpaste Tabs Mint -- 62 Tabs | Clean Age | Beauty & Personal Care | kaolin, calcium carbonate, limonene, menthol, sodium lauroyl sarcosinate, sodium bicarbonate, Sorbitol, stevioside | 2024-11-29 10:47:42 |
The Humble Co Dental Toothpaste Tablets Fluoride-Free -- 60 Tablets | The Humble Co | Beauty & Personal Care | kaolin, calcium carbonate, maltodextrin, menthol, sodium bicarbonate, stevioside | 2024-11-29 10:47:42 |
Unpaste Fluoride Toothpaste Tabs Cinnamon -- 1.4 oz | Unpaste | Beauty & Personal Care | citric acid, citric acid, stevia, sodium bicarbonate, stevioside | 2024-11-29 10:47:42 |
Unpaste Fluoride Toothpaste Tabs Mint -- 1.4 oz | Unpaste | Beauty & Personal Care | menthol, stevia, sodium bicarbonate, stevioside | 2024-11-29 10:47:42 |
Unpaste Fluoride-Free Toothpaste Tabs Mint -- 1.4 oz | Unpaste | Beauty & Personal Care | menthol, stevia, sodium bicarbonate, stevioside | 2024-11-29 10:47:42 |
Role | Description |
---|---|
sweetening agent | Substance that sweeten food, beverages, medications, etc. |
antioxidant | A substance that opposes oxidation or inhibits reactions brought about by dioxygen or peroxides. |
antineoplastic agent | A substance that inhibits or prevents the proliferation of neoplasms. |
hypoglycemic agent | A drug which lowers the blood glucose level. |
anti-inflammatory agent | Any compound that has anti-inflammatory effects. |
plant metabolite | Any eukaryotic metabolite produced during a metabolic reaction in plants, the kingdom that include flowering plants, conifers and other gymnosperms. |
[role information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res] |
Class | Description |
---|---|
diterpene glycoside | A terpene glycoside in which the terpene moiety is a diterpenoid. |
ent-kaurane diterpenoid | A diterpenoid compound having an ent-kaurane skeleton. |
beta-D-glucoside | Any D-glucoside in which the anomeric centre has beta-configuration. |
tetracyclic diterpenoid | A diterpenoid with a tetracyclic skeleton. |
bridged compound | A polycyclic compound in which two rings have two or more atoms in common. |
[compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res] |
Pathway | Proteins | Compounds |
---|---|---|
steviol glucoside biosynthesis (rebaudioside A biosynthesis) | 3 | 4 |
Assay ID | Title | Year | Journal | Article |
---|---|---|---|---|
AID1151320 | Antimicrobial activity against Aspergillus fumigatus ATCC 90906 | 2014 | Journal of natural products, May-23, Volume: 77, Issue:5 | Minor diterpene glycosides from the leaves of Stevia rebaudiana. |
AID348195 | Cytotoxicity against human Raji cells assessed as cell viability at 10 mol ratio by trypan blue staining | 2009 | Bioorganic & medicinal chemistry, Jan-15, Volume: 17, Issue:2 | Cancer preventive agents. Part 8: Chemopreventive effects of stevioside and related compounds. |
AID335365 | Effect on renal excretion in Wistar rat assessed as glomerular filtration rate at 4 mg/kg/hr, iv (RVb=1.39 %) | 1992 | Journal of natural products, May, Volume: 55, Issue:5 | Renal excretion of stevioside in rats. |
AID335359 | Effect on renal excretion in Wistar rat assessed as fractional sodium excretion at 8 mg/kg/hr, iv (RVb=0.58 %) | 1992 | Journal of natural products, May, Volume: 55, Issue:5 | Renal excretion of stevioside in rats. |
AID335357 | Effect on renal excretion in Wistar rat assessed as glucose clearance at 16 mg/kg/hr, iv (RVb=0 ml/min/kg) | 1992 | Journal of natural products, May, Volume: 55, Issue:5 | Renal excretion of stevioside in rats. |
AID397122 | Inhibition of HIV1 RT | |||
AID335360 | Effect on renal excretion in Wistar rat assessed as fractional sodium excretion at 12 mg/kg/hr, iv (RVb=0.70 %) | 1992 | Journal of natural products, May, Volume: 55, Issue:5 | Renal excretion of stevioside in rats. |
AID1151323 | Antimicrobial activity against Pseudomonas aeruginosa ATCC 27853 | 2014 | Journal of natural products, May-23, Volume: 77, Issue:5 | Minor diterpene glycosides from the leaves of Stevia rebaudiana. |
AID348188 | Inhibition of TPA-induced EBV-early antigen activation in human Raji cells at 500 mol ratio after 48hrs by indirect immunofluorescence technique relative to control | 2009 | Bioorganic & medicinal chemistry, Jan-15, Volume: 17, Issue:2 | Cancer preventive agents. Part 8: Chemopreventive effects of stevioside and related compounds. |
AID1406775 | Induction of insulin sensitivity in Syrian golden hamster assessed as uplift of glucose uptake in insulin-resistance condition relative to control | 2018 | European journal of medicinal chemistry, Aug-05, Volume: 156 | Diterpenoid lead stevioside and its hydrolysis products steviol and isosteviol: Biological activity and structural modification. |
AID1151316 | Antimalarial activity against chloroquine-sensitive Plasmodium falciparum D6 | 2014 | Journal of natural products, May-23, Volume: 77, Issue:5 | Minor diterpene glycosides from the leaves of Stevia rebaudiana. |
AID335348 | Effect on renal excretion in Wistar rat assessed as p-aminohippuric acid clearance at 12 mg/kg/hr, iv administered 30 mins after p-aminohippuric acid infusion (RVb=15.38 ml/min/kg) | 1992 | Journal of natural products, May, Volume: 55, Issue:5 | Renal excretion of stevioside in rats. |
AID348198 | Inhibition of DMBA-induced/TPA-promoted carcinogenesis in mouse assessed as reduction in skin papillomas bearing mouse at 85 nmol administered 1 hr before TPA treatment measured after 20 weeks | 2009 | Bioorganic & medicinal chemistry, Jan-15, Volume: 17, Issue:2 | Cancer preventive agents. Part 8: Chemopreventive effects of stevioside and related compounds. |
AID348211 | Reduction in peroxynitrite-induced/TPA-promoted number of skin papillomas in Sencar mouse after 20 weeks | 2009 | Bioorganic & medicinal chemistry, Jan-15, Volume: 17, Issue:2 | Cancer preventive agents. Part 8: Chemopreventive effects of stevioside and related compounds. |
AID90382 | Sensory evaluation was done at a concentration of 500 p.p.m. against property of sweetness. | 1985 | Journal of medicinal chemistry, Jan, Volume: 28, Issue:1 | Diterpenoid sweeteners. Synthesis and sensory evaluation of stevioside analogues with improved organoleptic properties. |
AID348193 | Cytotoxicity against human Raji cells assessed as cell viability at 500 mol ratio by trypan blue staining | 2009 | Bioorganic & medicinal chemistry, Jan-15, Volume: 17, Issue:2 | Cancer preventive agents. Part 8: Chemopreventive effects of stevioside and related compounds. |
AID335363 | Effect on renal excretion in Wistar rat assessed as glomerular filtration rate at 8 mg/kg/hr, iv (RVb=1.47 %) | 1992 | Journal of natural products, May, Volume: 55, Issue:5 | Renal excretion of stevioside in rats. |
AID1151317 | Antimalarial activity against chloroquine-resistant Plasmodium falciparum W2 | 2014 | Journal of natural products, May-23, Volume: 77, Issue:5 | Minor diterpene glycosides from the leaves of Stevia rebaudiana. |
AID348189 | Inhibition of TPA-induced EBV-early antigen activation in human Raji cells at 100 mol ratio after 48hrs by indirect immunofluorescence technique relative to control | 2009 | Bioorganic & medicinal chemistry, Jan-15, Volume: 17, Issue:2 | Cancer preventive agents. Part 8: Chemopreventive effects of stevioside and related compounds. |
AID348206 | Inhibition of peroxynitrite-induced/TPA-promoted carcinogenesis in Sencar mouse assessed as number of skin papillomas per mouse at 85 nmol administered 1 hr before TPA treatment measured after 11 weeks | 2009 | Bioorganic & medicinal chemistry, Jan-15, Volume: 17, Issue:2 | Cancer preventive agents. Part 8: Chemopreventive effects of stevioside and related compounds. |
AID348204 | Inhibition of peroxynitrite-induced/TPA-promoted carcinogenesis in Sencar mouse assessed as reduction in skin papillomas bearing mouse at 85 nmol administered 1 hr before TPA treatment measured after 15 weeks | 2009 | Bioorganic & medicinal chemistry, Jan-15, Volume: 17, Issue:2 | Cancer preventive agents. Part 8: Chemopreventive effects of stevioside and related compounds. |
AID348197 | Inhibition of DMBA-induced/TPA-promoted carcinogenesis in mouse assessed as reduction in skin papillomas bearing mouse at 85 nmol administered 1 hr before TPA treatment measured after 15 weeks | 2009 | Bioorganic & medicinal chemistry, Jan-15, Volume: 17, Issue:2 | Cancer preventive agents. Part 8: Chemopreventive effects of stevioside and related compounds. |
AID1151321 | Antimicrobial activity against methicillin-resistant Staphylococcus aureus ATCC 43300 | 2014 | Journal of natural products, May-23, Volume: 77, Issue:5 | Minor diterpene glycosides from the leaves of Stevia rebaudiana. |
AID211850 | Acute toxicity in mice after oral administration | 1981 | Journal of medicinal chemistry, Nov, Volume: 24, Issue:11 | Diterpenoid sweeteners. Synthesis and sensory evaluation of stevioside analogues nondegradable to steviol. |
AID335358 | Effect on renal excretion in Wistar rat assessed as fractional sodium excretion at 4 mg/kg/hr, iv (RVb=0.61 %) | 1992 | Journal of natural products, May, Volume: 55, Issue:5 | Renal excretion of stevioside in rats. |
AID348190 | Inhibition of TPA-induced EBV-early antigen activation in human Raji cells at 10 mol ratio after 48hrs by indirect immunofluorescence technique relative to control | 2009 | Bioorganic & medicinal chemistry, Jan-15, Volume: 17, Issue:2 | Cancer preventive agents. Part 8: Chemopreventive effects of stevioside and related compounds. |
AID335347 | Effect on renal excretion in Wistar rat assessed as p-aminohippuric acid clearance at 8 mg/kg/hr, iv administered 30 mins after p-aminohippuric acid infusion (RVb=15.60 ml/min/kg) | 1992 | Journal of natural products, May, Volume: 55, Issue:5 | Renal excretion of stevioside in rats. |
AID335350 | Clearance in Wistar rat at 4 mg/kg/hr, iv | 1992 | Journal of natural products, May, Volume: 55, Issue:5 | Renal excretion of stevioside in rats. |
AID335353 | Clearance in Wistar rat at 16 mg/kg/hr, iv | 1992 | Journal of natural products, May, Volume: 55, Issue:5 | Renal excretion of stevioside in rats. |
AID348192 | Cytotoxicity against human Raji cells assessed as cell viability at 1000 mol ratio by trypan blue staining | 2009 | Bioorganic & medicinal chemistry, Jan-15, Volume: 17, Issue:2 | Cancer preventive agents. Part 8: Chemopreventive effects of stevioside and related compounds. |
AID335349 | Effect on renal excretion in Wistar rat assessed as p-aminohippuric acid clearance at 16 mg/kg/hr, iv administered 30 mins after p-aminohippuric acid infusion (RVb=16.70 ml/min/kg) | 1992 | Journal of natural products, May, Volume: 55, Issue:5 | Renal excretion of stevioside in rats. |
AID754153 | Antioxidant activity assessed as hydroxyl radical scavenging activity | 2013 | Journal of natural products, Jun-28, Volume: 76, Issue:6 | Steviol glycosides: chemical diversity, metabolism, and function. |
AID400253 | Inhibition of 12-O-tetradecanoylphorbol-13-acetate-induced EBV-early antigen activation in human Raji cells assessed as EA activation at 1000 molar ratio after 48 hrs relative to TPA | 2004 | Journal of natural products, Mar, Volume: 67, Issue:3 | Microbial transformation of isosteviol and inhibitory effects on Epstein-Barr virus activation of the transformation products. |
AID335351 | Clearance in Wistar rat at 8 mg/kg/hr, iv | 1992 | Journal of natural products, May, Volume: 55, Issue:5 | Renal excretion of stevioside in rats. |
AID335364 | Effect on renal excretion in Wistar rat assessed as glomerular filtration rate at 12 mg/kg/hr, iv (RVb=1.87 %) | 1992 | Journal of natural products, May, Volume: 55, Issue:5 | Renal excretion of stevioside in rats. |
AID335352 | Clearance in Wistar rat at 12 mg/kg/hr, iv | 1992 | Journal of natural products, May, Volume: 55, Issue:5 | Renal excretion of stevioside in rats. |
AID348194 | Cytotoxicity against human Raji cells assessed as cell viability at 100 mol ratio by trypan blue staining | 2009 | Bioorganic & medicinal chemistry, Jan-15, Volume: 17, Issue:2 | Cancer preventive agents. Part 8: Chemopreventive effects of stevioside and related compounds. |
AID400255 | Inhibition of 12-O-tetradecanoylphorbol-13-acetate-induced EBV-early antigen activation in human Raji cells assessed as EA activation at 100 molar ratio after 48 hrs relative to TPA | 2004 | Journal of natural products, Mar, Volume: 67, Issue:3 | Microbial transformation of isosteviol and inhibitory effects on Epstein-Barr virus activation of the transformation products. |
AID1151318 | Antimicrobial activity against Candida albicans ATCC 90028 | 2014 | Journal of natural products, May-23, Volume: 77, Issue:5 | Minor diterpene glycosides from the leaves of Stevia rebaudiana. |
AID335354 | Effect on renal excretion in Wistar rat assessed as glucose clearance at 4 mg/kg/hr, iv (RVb=0 ml/min/kg) | 1992 | Journal of natural products, May, Volume: 55, Issue:5 | Renal excretion of stevioside in rats. |
AID89768 | Sensory evaluation was done for sweetness at a concentration of 500 p.p.m. against sample intensity relative to 10% sucrose. | 1985 | Journal of medicinal chemistry, Jan, Volume: 28, Issue:1 | Diterpenoid sweeteners. Synthesis and sensory evaluation of stevioside analogues with improved organoleptic properties. |
AID348187 | Inhibition of TPA-induced EBV-early antigen activation in human Raji cells at 1000 mol ratio after 48hrs by indirect immunofluorescence technique relative to control | 2009 | Bioorganic & medicinal chemistry, Jan-15, Volume: 17, Issue:2 | Cancer preventive agents. Part 8: Chemopreventive effects of stevioside and related compounds. |
AID335356 | Effect on renal excretion in Wistar rat assessed as glucose clearance at 12 mg/kg/hr, iv (RVb=0 ml/min/kg) | 1992 | Journal of natural products, May, Volume: 55, Issue:5 | Renal excretion of stevioside in rats. |
AID335346 | Effect on renal excretion in Wistar rat assessed as p-aminohippuric acid clearance at 4 mg/kg/hr, iv administered 30 mins after p-aminohippuric acid infusion (RVb=12.88 ml/min/kg) | 1992 | Journal of natural products, May, Volume: 55, Issue:5 | Renal excretion of stevioside in rats. |
AID1151324 | Antimicrobial activity against Mycobacterium intracellulare ATCC 23068 | 2014 | Journal of natural products, May-23, Volume: 77, Issue:5 | Minor diterpene glycosides from the leaves of Stevia rebaudiana. |
AID400257 | Cytotoxicity against human Raji cells assessed as cell viability at 1000 molar ratio by trypan blue assay | 2004 | Journal of natural products, Mar, Volume: 67, Issue:3 | Microbial transformation of isosteviol and inhibitory effects on Epstein-Barr virus activation of the transformation products. |
AID348208 | Inhibition of peroxynitrite-induced/TPA-promoted carcinogenesis in Sencar mouse assessed as number of skin papillomas per mouse at 85 nmol administered 1 hr before TPA treatment measured after 20 weeks | 2009 | Bioorganic & medicinal chemistry, Jan-15, Volume: 17, Issue:2 | Cancer preventive agents. Part 8: Chemopreventive effects of stevioside and related compounds. |
AID400254 | Inhibition of 12-O-tetradecanoylphorbol-13-acetate-induced EBV-early antigen activation in human Raji cells assessed as EA activation at 500 molar ratio after 48 hrs relative to TPA | 2004 | Journal of natural products, Mar, Volume: 67, Issue:3 | Microbial transformation of isosteviol and inhibitory effects on Epstein-Barr virus activation of the transformation products. |
AID348191 | Inhibition of TPA-induced EBV-early antigen activation in human Raji cells after 48hrs by indirect immunofluorescence technique | 2009 | Bioorganic & medicinal chemistry, Jan-15, Volume: 17, Issue:2 | Cancer preventive agents. Part 8: Chemopreventive effects of stevioside and related compounds. |
AID335345 | Effect on renal excretion in Wistar rat assessed as inulin clearance at 16 mg/kg/hr, iv administered 30 mins after inulin infusion (RVb=6.29 ml/min/kg) | 1992 | Journal of natural products, May, Volume: 55, Issue:5 | Renal excretion of stevioside in rats. |
AID379153 | Agonist activity at glucocorticoid receptor transfected in mouse RAW264.7 cells assessed as firefly/renilla luciferase ratio at 10 uM by dual liciferase reporter assay | 2006 | Journal of natural products, Oct, Volume: 69, Issue:10 | Transformation of steviol-16alpha,17-epoxide by Streptomyces griseus and Cunninghamella bainieri. |
AID90230 | Sensory evaluation was done for sweetness at a concentration of 500 p.p.m. against compound potency calculated on weight basis. | 1985 | Journal of medicinal chemistry, Jan, Volume: 28, Issue:1 | Diterpenoid sweeteners. Synthesis and sensory evaluation of stevioside analogues with improved organoleptic properties. |
AID348205 | Inhibition of peroxynitrite-induced/TPA-promoted carcinogenesis in Sencar mouse assessed as reduction in skin papillomas bearing mouse at 85 nmol administered 1 hr before TPA treatment measured after 20 weeks | 2009 | Bioorganic & medicinal chemistry, Jan-15, Volume: 17, Issue:2 | Cancer preventive agents. Part 8: Chemopreventive effects of stevioside and related compounds. |
AID90092 | Sensory evaluation was done for sweetness at a concentration of 500 p.p.m. against compound potency calculated on a molar basis. | 1985 | Journal of medicinal chemistry, Jan, Volume: 28, Issue:1 | Diterpenoid sweeteners. Synthesis and sensory evaluation of stevioside analogues with improved organoleptic properties. |
AID348196 | Inhibition of DMBA-induced/TPA-promoted carcinogenesis in mouse assessed as reduction in skin papillomas bearing mouse at 85 nmol administered 1 hr before TPA treatment measured after 9 weeks | 2009 | Bioorganic & medicinal chemistry, Jan-15, Volume: 17, Issue:2 | Cancer preventive agents. Part 8: Chemopreventive effects of stevioside and related compounds. |
AID90380 | Sensory evaluation was done at a concentration of 500 p.p.m. against other properties. | 1985 | Journal of medicinal chemistry, Jan, Volume: 28, Issue:1 | Diterpenoid sweeteners. Synthesis and sensory evaluation of stevioside analogues with improved organoleptic properties. |
AID1151319 | Antimicrobial activity against Cryptococcus neoformans ATCC 90113 | 2014 | Journal of natural products, May-23, Volume: 77, Issue:5 | Minor diterpene glycosides from the leaves of Stevia rebaudiana. |
AID400256 | Inhibition of 12-O-tetradecanoylphorbol-13-acetate-induced EBV-early antigen activation in human Raji cells assessed as EA activation at 10 molar ratio after 48 hrs relative to TPA | 2004 | Journal of natural products, Mar, Volume: 67, Issue:3 | Microbial transformation of isosteviol and inhibitory effects on Epstein-Barr virus activation of the transformation products. |
AID335355 | Effect on renal excretion in Wistar rat assessed as glucose clearance at 8 mg/kg/hr, iv (RVb=0 ml/min/kg) | 1992 | Journal of natural products, May, Volume: 55, Issue:5 | Renal excretion of stevioside in rats. |
AID1406776 | Downregulation of glucose uptake in Syrian golden hamster jejunum at 1 mM after 60 mins relative to control | 2018 | European journal of medicinal chemistry, Aug-05, Volume: 156 | Diterpenoid lead stevioside and its hydrolysis products steviol and isosteviol: Biological activity and structural modification. |
AID348207 | Inhibition of peroxynitrite-induced/TPA-promoted carcinogenesis in Sencar mouse assessed as number of skin papillomas per mouse at 85 nmol administered 1 hr before TPA treatment measured after 15 weeks | 2009 | Bioorganic & medicinal chemistry, Jan-15, Volume: 17, Issue:2 | Cancer preventive agents. Part 8: Chemopreventive effects of stevioside and related compounds. |
AID335342 | Effect on renal excretion in Wistar rat assessed as inulin clearance at 4 mg/kg/hr, iv administered 30 mins after inulin infusion (RVb=6.66 ml/min/kg) | 1992 | Journal of natural products, May, Volume: 55, Issue:5 | Renal excretion of stevioside in rats. |
AID1406774 | Induction of insulin sensitivity in Syrian golden hamster assessed as uplift of glucose uptake in normal condition relative to control | 2018 | European journal of medicinal chemistry, Aug-05, Volume: 156 | Diterpenoid lead stevioside and its hydrolysis products steviol and isosteviol: Biological activity and structural modification. |
AID90381 | Sensory evaluation was done at a concentration of 500 p.p.m. against property of bitterness. | 1985 | Journal of medicinal chemistry, Jan, Volume: 28, Issue:1 | Diterpenoid sweeteners. Synthesis and sensory evaluation of stevioside analogues with improved organoleptic properties. |
AID335343 | Effect on renal excretion in Wistar rat assessed as inulin clearance at 8 mg/kg/hr, iv administered 30 mins after inulin infusion (RVb=6.33 ml/min/kg) | 1992 | Journal of natural products, May, Volume: 55, Issue:5 | Renal excretion of stevioside in rats. |
AID348203 | Inhibition of peroxynitrite-induced/TPA-promoted carcinogenesis in Sencar mouse assessed as reduction in skin papillomas bearing mouse at 85 nmol administered 1 hr before TPA treatment measured after 11 weeks | 2009 | Bioorganic & medicinal chemistry, Jan-15, Volume: 17, Issue:2 | Cancer preventive agents. Part 8: Chemopreventive effects of stevioside and related compounds. |
AID335344 | Effect on renal excretion in Wistar rat assessed as inulin clearance at 12 mg/kg/hr, iv administered 30 mins after inulin infusion (RVb=5.69 ml/min/kg) | 1992 | Journal of natural products, May, Volume: 55, Issue:5 | Renal excretion of stevioside in rats. |
AID335362 | Effect on renal excretion in Wistar rat assessed as glomerular filtration rate at 4 mg/kg/hr, iv (RVb=1.41 %) | 1992 | Journal of natural products, May, Volume: 55, Issue:5 | Renal excretion of stevioside in rats. |
AID335361 | Effect on renal excretion in Wistar rat assessed as fractional sodium excretion at 16 mg/kg/hr, iv (RVb=0.60 %) | 1992 | Journal of natural products, May, Volume: 55, Issue:5 | Renal excretion of stevioside in rats. |
AID1151322 | Antimicrobial activity against Escherichia coli ATCC 35218 | 2014 | Journal of natural products, May-23, Volume: 77, Issue:5 | Minor diterpene glycosides from the leaves of Stevia rebaudiana. |
[information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023] |
Timeframe | Studies, This Drug (%) | All Drugs % |
---|---|---|
pre-1990 | 16 (3.74) | 18.7374 |
1990's | 33 (7.71) | 18.2507 |
2000's | 70 (16.36) | 29.6817 |
2010's | 197 (46.03) | 24.3611 |
2020's | 112 (26.17) | 2.80 |
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] |
According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be strong demand-to-supply ratio for research on this compound.
| This Compound (36.58) All Compounds (24.57) |
Publication Type | This drug (%) | All Drugs (%) |
---|---|---|
Trials | 13 (2.84%) | 5.53% |
Reviews | 38 (8.32%) | 6.00% |
Case Studies | 1 (0.22%) | 4.05% |
Observational | 0 (0.00%) | 0.25% |
Other | 405 (88.62%) | 84.16% |
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] |